Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,649 | 4,619 | N/A | N/A | N/A |
| Other current assets | 0 | 2,330 | 0 | 0 | 0 |
| TOTAL | $70,267 | $7,066 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 132 | 114 | N/A | N/A | N/A |
| Other Non-Current Assets | 59 | 62 | 0 | 0 | 0 |
| TOTAL | $191 | $176 | $N/A | $N/A | $N/A |
| Total Assets | $70,458 | $7,242 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,482 | 3,679 | 0 | 0 | 0 |
| TOTAL | $3,482 | $18,112 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 11,485 | 0 | 0 | 0 |
| TOTAL | $N/A | $11,485 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,482 | $29,597 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,317 | 23,274 | N/A | N/A | N/A |
| Common Shares | 23 | 1 | N/A | N/A | N/A |
| Retained earnings | -95,068 | -84,790 | N/A | N/A | N/A |
| Other shareholders' equity | 0 | 61,311 | 0 | 0 | 0 |
| TOTAL | $66,976 | $-22,355 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $70,458 | $7,242 | $0 | $0 | $0 |